ValuEngine lowered shares of Houlihan Lokey (NYSE:HLI) from a hold rating to a sell rating in a research note released on Monday, ValuEngine reports.

Several other equities analysts have also recently issued reports on the company. Zacks Investment Research upgraded Eutelsat Communications from a hold rating to a strong-buy rating and set a $21.00 target price on the stock in a research report on Wednesday, June 12th. JMP Securities dropped their target price on BioCryst Pharmaceuticals from $18.00 to $10.00 and set an outperform rating on the stock in a research report on Thursday, May 23rd. Finally, Goldman Sachs Group reiterated a sell rating and set a $45.00 target price on shares of Intel in a research report on Wednesday, April 3rd. One analyst has rated the stock with a sell rating, two have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of Buy and a consensus price target of $50.08.

HLI stock traded up $0.21 during trading on Monday, hitting $43.40. The company had a trading volume of 332,924 shares, compared to its average volume of 247,290. The stock has a market cap of $3.03 billion, a price-to-earnings ratio of 15.12, a PEG ratio of 1.21 and a beta of 0.97. Houlihan Lokey has a 1-year low of $34.31 and a 1-year high of $53.20. The company has a 50-day simple moving average of $45.38. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.76 and a current ratio of 0.76.

Houlihan Lokey (NYSE:HLI) last issued its quarterly earnings results on Wednesday, May 8th. The financial services provider reported $0.86 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.69 by $0.17. The firm had revenue of $291.40 million for the quarter, compared to analysts’ expectations of $266.26 million. Houlihan Lokey had a return on equity of 22.31% and a net margin of 14.67%. The firm’s revenue for the quarter was up 19.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.65 EPS. As a group, research analysts forecast that Houlihan Lokey will post 2.99 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Monday, June 3rd were paid a dividend of $0.31 per share. This is a positive change from Houlihan Lokey’s previous quarterly dividend of $0.27. The ex-dividend date was Friday, May 31st. This represents a $1.24 annualized dividend and a dividend yield of 2.86%. Houlihan Lokey’s payout ratio is 43.21%.

In other news, major shareholder Orix Hlhz Holding Llc sold 3,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $45.52, for a total transaction of $136,560,000.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 80.50% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the company. American Century Companies Inc. purchased a new stake in shares of Houlihan Lokey during the 4th quarter worth approximately $3,390,000. Pier Capital LLC purchased a new stake in shares of Houlihan Lokey during the 1st quarter worth approximately $8,518,000. Natixis Advisors L.P. boosted its stake in shares of Houlihan Lokey by 17.8% during the 4th quarter. Natixis Advisors L.P. now owns 163,361 shares of the financial services provider’s stock worth $6,011,000 after acquiring an additional 24,682 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Houlihan Lokey by 11.5% during the 4th quarter. Thrivent Financial for Lutherans now owns 427,863 shares of the financial services provider’s stock worth $15,746,000 after acquiring an additional 44,053 shares in the last quarter. Finally, Tibra Equities Europe Ltd purchased a new stake in shares of Houlihan Lokey during the 1st quarter worth approximately $477,000. 58.04% of the stock is currently owned by institutional investors and hedge funds.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), financing, financial restructuring, and financial advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial Advisory Services. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions.

Featured Article: How to Invest in Marijuana Stocks

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Houlihan Lokey (NYSE:HLI)

Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.